Home / Compare / Retatrutide vs Tirzepatide
Retatrutide vs Tirzepatide
Retatrutide vs Tirzepatide: how they work, doses used, FDA status and trial weight loss (28.3% vs 20.9%), with sources.
| Retatrutide | Tirzepatide | |
|---|---|---|
| Works on | GIP + GLP-1 + glucagon (triple agonist) | GIP + GLP-1 (dual agonist) |
| How it is taken | Injection, once weekly | Injection, once weekly (Mounjaro, Zepbound) |
| US status | Phase 3, not approved (filing planned early 2027) | FDA-approved (2022 diabetes, 2023 weight) |
| Highest dose | 12 mg weekly (highest trial dose) | 15 mg weekly (label) |
| Key trial | TRIUMPH-1 (phase 3) | SURMOUNT-1 (phase 3) |
| Average weight loss | 28.3% at 80 weeks (12 mg weekly) | 20.9% at 72 weeks (15 mg weekly) |
| Placebo in that trial | not stated in our source | 3.1% |
Not a head-to-head comparison. The weight-loss numbers come from separate trials with different people, doses and lengths. A direct trial is the only way to know which works better.
How they differ
Retatrutide works on gip + glp-1 + glucagon (triple agonist); Tirzepatide works on gip + glp-1 (dual agonist). Retatrutide is taken as: injection, once weekly.Tirzepatide is taken as: injection, once weekly (mounjaro, zepbound).
Dose schedules and warnings: Retatrutide dosage chart ยท Tirzepatide dosage chart.
Questions
- Is retatrutide stronger than tirzepatide?
- No trial has compared them directly. In separate trials, Retatrutide averaged 28.3% weight loss (TRIUMPH-1 (phase 3), 80 weeks) and Tirzepatide 20.9% (SURMOUNT-1 (phase 3), 72 weeks). Different trials enroll different people over different lengths of time, so the numbers are not a fair head-to-head comparison.
- Is retatrutide FDA-approved?
- Phase 3, not approved (filing planned early 2027).
- Is tirzepatide FDA-approved?
- FDA-approved (2022 diabetes, 2023 weight).
Sources
- AJMC: Retatrutide achieves up to 30.3% average weight loss in phase 3 TRIUMPH-1
- Jastreboff et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). NEJM 2022
Last checked 2026-11-16. How we pick and check sources: methodology.